TM

Trishla Mehta

Active Director Director DIN 07476195
DIN 07476195 First appointment Apr 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2016
Shareholding value •••• Premium profile

About Trishla Mehta

Data last updated:

Trishla Mehta is a Director at Ravi Pharma Trade Private Limited (since 2016). The company operates in Trading. Ravi Pharma Trade Private Limited reported revenue of ₹31.3 Lakh (FY 2024).

DIN 07476195
Primary Designation Director
Industry Trading
First Appointment 28 Apr 2016
Oldest Company Age 10 yrs
Largest company Ravi Pharma Trade Private Limited · ₹31.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ravi Pharma Trade Private Limited U24302RJ2016PTC054763
Director28 Apr 20162016₹31.3 Lakh (FY 2024)Active

Board colleagues of Trishla Mehta

Directorship timeline

Open interactive timeline →
Ravi Pharma Trade Private Limited
Premium access

Shareholding and investment profile for Trishla Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Trishla Mehta

Trishla Mehta currently holds 1 directorship: Ravi Pharma Trade Private Limited (Director, since 28 Apr 2016, revenue ₹31.3 Lakh (FY 2024)).

Trishla Mehta was first appointed on 28 Apr 2016 as Director at Ravi Pharma Trade Private Limited.

The current boards of Trishla Mehta's companies include Akansha Mehta (Ravi Pharma Trade Private Limited), Ravi Kishore Mehta (Ravi Pharma Trade Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available